BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 159511)

  • 1. Action of brinase on human fibrinogen and plasminogen.
    Vanhove P; Donati MB; Claeys H; Verhaeghe R; Vermylen J
    Thromb Haemost; 1979 Aug; 42(2):571-81. PubMed ID: 159511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of brinase on fibrinogen: fibrin transition in in vitro and in vivo studies. I. Influence of in vitro addition of brinase to plasma on the ethanol gelation test.
    Frisch EP
    Haemostasis; 1980; 9(1):1-8. PubMed ID: 7351312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of brinase on fibrinogen: fibrin transition in vitro and in vivo studies. II. Induction of fibrin deposits by brinase in the kidneys of rats with inhibited fibrinolysis.
    Saldeen T; Frisch EP
    Haemostasis; 1982; 11(3):161-9. PubMed ID: 7047313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of brinase on fibrinogen in vivo.
    Nyman D
    Thromb Diath Haemorrh; 1975 Apr; 33(2):217-20. PubMed ID: 1138418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of adsorbed fibrinogen by surface-generated plasmin.
    Brash JL; Chan BM; Szota P; Thibodeau JA
    J Biomed Mater Res; 1985; 19(9):1017-29. PubMed ID: 2935535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
    Hare TR; Gardell SJ
    Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative ex vivo study of plasminogen activators and proteases for fibrinolytic activity and side effects in rabbits.
    Janik BA; Papaioannou SE
    Thromb Haemost; 1977 Feb; 37(1):154-61. PubMed ID: 576512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the degradation of fibrinogen by proteolytic enzymes from the larvae of Lanomia achelous (Cramer).
    Arocha-Piñango CL; Perales J; Carvajal Z
    Thromb Haemost; 1981 Jun; 45(3):233-6. PubMed ID: 6456570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteases during the growth of Ehrlich ascites tumor. I. The fibrinolysin system.
    LeBlanc PP; Back N
    J Natl Cancer Inst; 1975 Apr; 54(4):881-6. PubMed ID: 123966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of proteins adsorbed from human plasma to glass bead columns: plasmin-induced degradation of adsorbed fibrinogen.
    Brash JL; Thibodeau JA
    J Biomed Mater Res; 1986; 20(9):1263-75. PubMed ID: 2946694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease.
    Kim PY; Stewart RJ; Lipson SM; Nesheim ME
    J Thromb Haemost; 2007 Jun; 5(6):1250-6. PubMed ID: 17266698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinolytic properties and thrombolytic effect of a novel fibrinolytic enzyme from Streptomyces sp. Y405].
    Wang M; Wang J; Shao M; Wang M; Wang Y
    Yao Xue Xue Bao; 1998 Jul; 33(7):481-5. PubMed ID: 12016879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen assay by means of the lysis time method.
    Berg W; Korsan-Bengtsen K; Ygge J
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):127-44. PubMed ID: 16955971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of a thrombolytic agent, protease I (Aspergillus enzyme, Brinase) on fibrinogen turnover.
    Cultrera G; Manai G; Gibelli A
    Farmaco Sci; 1973 Nov; 28(11):907-11. PubMed ID: 4762843
    [No Abstract]   [Full Text] [Related]  

  • 19. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the proteolysis of fibrinogen and fibrin by Aspergillus ochraceus enzyme as compared to the action of plasmin.
    Teisseyre E; Latallo ZS; Kopeć M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):99-110. PubMed ID: 4134484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.